We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 12.50 | 0.76% | 1,648.50 | 1,649.00 | 1,650.00 | 1,656.00 | 1,635.00 | 1,642.00 | 1,454,664 | 12:16:36 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 13.78 | 67.93B |
From Apr 2019 to Apr 2024
TIDMGSK
RNS Number : 5609H
GlaxoSmithKline PLC
16 March 2015
GlaxoSmithKline plc
Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
In accordance with DTR 3.1.4 R(1)(a) and (c) GlaxoSmithKline plc (GSK) was advised on 16 March 2015 of the following increase in the notional allocation of GSK American Depositary Shares (ADSs) on 13 March 2015, at a price of $46.37 per ADS, following the revaluation of the cash element of the notional investment held within the GSK 401K plan:
Director/PDMR Number of ADSs ----------------- ----------------- Dr M M Slaoui 14 ----------------- ----------------- Connected person Number of ADSs -------------------------- ----------------- Dr K Slaoui (connected person of Dr M M Slaoui) 42 -------------------------- -----------------
V A Whyte
Company Secretary
16 March 2015
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSEQLFFEXFLBBL
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
